Replies to post #21838 on Ayala Pharmaceuticals Inc (ADXS)

[CATTDOGG12347]

I think it depends on how a deal is structured and what is actually being given up.

[fraud fighter]

Why would a BP enter into a deal prior to receiving EU approval and run any risk?

[ignatiusrielly35]

I disagree, Meisha. There is no reason to wait for EMA approval to sign a distribution deal. Since they can pre-analyze what approval would be worth, DOC could simply do the deal now and have the agreement call for a large milestone payment upon approval. That would result in capturing the full value of the deal to ADXS without waiting until after approval, which would create a delay in getting to market. In addition, DOC would be reckless to wait until the EMA decision because if conditional approval is denied it will be more difficult to raise money at that point. The smart play is to do the deal now, with a reasonable amount of cash upfront and big milestones.